Swiss Diabetes Registry - SwissDiab Study
Recruiting now
Conditions studied: Diabetes Mellitus
In brief
Currently, the estimated number of people with diabetes mellitus is approximately 387 million people worldwide. Due to population growth, urbanization, ageing and the rising prevalence of obesity the numbers of individuals with diabetes is increasing likewise. It has been shown that improving glycemic control is associated with a reduction in late complications of diabetes, such as cardiovascular and microvascular diseases. Therefore, treatment guidelines were established internationally by large and renowned associations and adopted by many countries. For Switzerland only sparse data exist on the actual implementation of such recommendations and on patient's well-being. The Swiss Diabetes Registry - SwissDiab Study is a prospective cohort study aiming at including and collecting data of virtually all patients regularly seen and treated at the study centers (≈ 500 patients each), irrespective of type, duration of diabetes or treatment . This allows the evaluation of diabetes treatment strategies at these centers. Furthermore, risk indicators for micro- and macrovascular complications, mortality as well as costs and quality of life will be assessed. Data will be recorded through an internet-based, electronic database specifically designed for this study. At a later perspective it is planned to extend data collection to general practitioner/family doctor networks in order to include a larger and more representative sample of patients with diabetes in Switzerland.
Key facts
- Study ID
- NCT01179815
- Run by
- Insel Gruppe AG, University Hospital Bern
- People needed
- 1500
- Starts
- 2010-01-01
- Expected to finish
- 2099-01-01
- Last updated by the study team
- 2026-06-11
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age > 18 years
- Diagnosis of diabetes mellitus according to ADA criteria
- Informed consent
You may not qualify if…
- Patients with gestational diabetes mellitus, patients unable to give informed consent, legally incompetent or incapable to comply with the study terms and conditions as well as patients with significantly reduced life expectancy (<1 year) will be excluded
Where it is running
- Universitätspoliklinik für Endokrinologie, Diabetologie und Klinische Ernährung, Inselspital Bern — Bern, Switzerland (enrolling)
- Service d'endocrinologie, diabétologie et métabolisme — Lausanne, Switzerland (enrolling)
- Klinik für Endokrinologie, Diabetologie, Osteologie und Stoffwechselerkrankungen, Kantonsspital St.Gallen — Sankt Gallen, Switzerland (enrolling)
- Klinik für Endokrinologie, Diabetologie und Klinische Ernährung, Universitätsspital Zürich — Zurich, Switzerland (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.